They feel better, so they revert to old eating patterns: bigger meals, less protein tracking, skipping the hydration schedule
By blunting dopamine release and reducing reward signaling in these areas, tirzepatide could theoretically reduce cravings for various substances and even non-substance compulsive behaviors
In fact, only 1.8% of patients discontinued treatment with tirzepatide due to side effects
Weight-loss success depends on: Dose progression Medical supervision Nutrition habits Consistency Lifestyle changes Side Effects Comparison -Mounjaro vs Semaglutide Both medications may cause: Nausea Vomiting Diarrhea Constipation Fatigue Appetite suppression Because Mounjaro is often more potent, some patients feel stronger side effects during early dose increases
Alternative treatment options vary by concern being treated
GHK-Cu is not intended to diagnose, treat, cure, or prevent any disease